Literature DB >> 5653025

Investigation of relation between use of oral contraceptives and thromboembolic disease.

M P Vessey, R Doll.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5653025      PMCID： PMC1985919          DOI： 10.1136/bmj.2.5599.199

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  19 in total

1.  Thrombosis and oestrogens.

Authors:  M F Oliver
Journal:  Lancet       Date:  1967-09-02       Impact factor: 79.321

2.  Puerperal thromboembolism and suppression of lactation.

Authors:  D G Daniel; H Campbell; A C Turnbull
Journal:  Lancet       Date:  1967-08-05       Impact factor: 79.321

3.  Some effects of oral contraceptives on serum-lipid and lipoprotein levels.

Authors:  J W Wynn; J W Doar; G L Mills
Journal:  Lancet       Date:  1966-10-01       Impact factor: 79.321

4.  Some effects of oral contraceptives on carbohydrate metabolism.

Authors:  V Wynn; J W Doar
Journal:  Lancet       Date:  1966-10-01       Impact factor: 79.321

5.  Influence of pregnancy and oral contraception on the incidence of strokes in women of childbearing age.

Authors:  W B Jennett; J N Cross
Journal:  Lancet       Date:  1967-05-13       Impact factor: 79.321

6.  Oral contraceptives and cerebral arterial occlusion.

Authors:  L Illis; R S Kocen; W I McDonald; V P Mondkar
Journal:  Br Med J       Date:  1965-11-13

7.  Cerebral arterial insufficiency and oral contraceptives.

Authors:  E R Bickerstaff; J M Holmes
Journal:  Br Med J       Date:  1967-03-25

8.  Pulmonary emboli in young adults.

Authors:  C A Loehry
Journal:  Br Med J       Date:  1966-05-28

9.  Massive pulmonary embolism in healthy people.

Authors:  H A Fleming; S M Bailey
Journal:  Br Med J       Date:  1966-05-28

10.  Diseases of the heart and blood-vessels. Venous thrombosis.

Authors:  R L Richards
Journal:  Br Med J       Date:  1966-07-23
View more
  74 in total

Review 1.  Complications of systemic oral contraceptive therapy: Neoplasm--breast, uterus, cervix and vagina.

Authors:  M A Sperling
Journal:  West J Med       Date:  1975-01

Review 2.  An analysis of the reported association of oral contraceptives to thromboembolic disease.

Authors:  W D Odell
Journal:  West J Med       Date:  1975-01

3.  [Stationary thromboprophylaxis in casualty surgery. Relevance of postoperative mobility and preexisting risk factors].

Authors:  R Eisele; E Maier; L Kinzl; U Gude
Journal:  Unfallchirurg       Date:  2004-04       Impact factor: 1.000

4.  The "top 50": a perspective on the BMJ drawn from the Science Citation Index.

Authors:  B Dixon
Journal:  BMJ       Date:  1990-10-03

Review 5.  A risk-benefit assessment of estrogen therapy in postmenopausal women.

Authors:  M P Cust; K F Gangar; T C Hillard; M I Whitehead
Journal:  Drug Saf       Date:  1990 Sep-Oct       Impact factor: 5.606

6.  Advising the profession.

Authors: 
Journal:  Br Med J       Date:  1969-12-27

Review 7.  Epidemiology of venous thromboembolism.

Authors:  W W Coon
Journal:  Ann Surg       Date:  1977-08       Impact factor: 12.969

8.  Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study.

Authors:  O Lidegaard
Journal:  BMJ       Date:  1993-04-10

9.  Effects of age, sex and the oral contraceptive on the platelet membrane fibrinogen binding site (glycoprotein IIb/IIIa).

Authors:  M Cahill; R Mistry; C Chapman; J K Wood; D B Barnett
Journal:  Br J Clin Pharmacol       Date:  1992-01       Impact factor: 4.335

10.  The effect of low-dose estroprogestinic preparations on prothrombin complex factors: no significant increase after an 8-month trial.

Authors:  A Girolami; M Procidano; M Vicariotto; G Cappellato; T Vicari
Journal:  Blut       Date:  1985-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.